Literature DB >> 36110378

Curcumin Diethyl γ-Aminobutyrate, a Prodrug of Curcumin, for Enhanced Treatment of Inflammatory Pain.

Peththa Wadu Dasuni Wasana1,2, Piyapan Suwattananuruk2, Somphob Thompho3, Worathat Thitikornpong4,5, Opa Vajragupta4,6, Pornchai Rojsitthisak4,5, Pasarapa Towiwat4,1.   

Abstract

Curcumin is a naturally occurring polyphenol compound with potential analgesic effects. It has been shown to improve pain-like behaviors in numerous models of pain. Despite its potential, curcumin exhibits poor physicochemical and pharmacokinetic properties, which hinder its oral therapeutic efficacy. Curcumin diethyl γ-aminobutyrate (CUR-2GE), a carbamate prodrug of curcumin, was designed to overcome these limitations and demonstrated greater anti-neuroinflammatory effects compared to curcumin in vitro. Thus, this study evaluated the effect of CUR-2GE and its parent compound on pain-like behaviors in carrageenan- and LPS-induced mouse models. The possible side effects of CUR-2GE were also assessed by exploring its effects on motor coordination and spontaneous locomotor activity after acute and chronic treatments. The results showed that CUR-2GE improved mechanical and thermal hyperalgesia and locomotor activity to a greater extent than curcumin in carrageenan-induced mice. These results are in line with the ability of CUR-2GE to suppress peripheral inflammation in the paw tissue of carrageenan-induced mice, indicated by a significant decrease in TNF-α and IL-6 expression levels. Similarly, in LPS-induced mice, CUR-2GE improved sickness and pain-like behaviors (exploratory behaviors and long-term locomotor activity) to a greater extent than curcumin. Furthermore, CUR-2GE significantly reduced the level of proinflammatory cytokines in both the plasma and spinal cord tissue of LPS-induced mice, exhibiting significantly higher inhibition than curcumin. Moreover, the motor coordination, and locomotive behaviors of mice were not affected by both acute and chronic administration of CUR-2GE, indicating no potential CNS side effects. Thus, CUR-2GE demonstrated enhanced therapeutic efficacy in mouse models of inflammatory pain without any possible CNS side effects, suggesting its potential to be developed as an analgesic agent against inflammatory pain.
© 2022 American Chemical Society.

Entities:  

Year:  2022        PMID: 36110378      PMCID: PMC9469498          DOI: 10.1021/acsptsci.2c00062

Source DB:  PubMed          Journal:  ACS Pharmacol Transl Sci        ISSN: 2575-9108


  52 in total

1.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

Review 2.  Amino acids as promoieties in prodrug design and development.

Authors:  Balvinder S Vig; Kristiina M Huttunen; Krista Laine; Jarkko Rautio
Journal:  Adv Drug Deliv Rev       Date:  2012-10-22       Impact factor: 15.470

3.  Neuroimmune mechanisms of pain: Basic science and potential therapeutic modulators.

Authors:  Jessica Sy Lim; Peter Ca Kam
Journal:  Anaesth Intensive Care       Date:  2020-02-26       Impact factor: 1.669

Review 4.  New perspectives in CNS safety pharmacology.

Authors:  Roger D Porsolt; Martine Lemaire; Niklaus Dürmüller; Sylvain Roux
Journal:  Fundam Clin Pharmacol       Date:  2002-06       Impact factor: 2.748

5.  Global patterns of opioid use and dependence: harms to populations, interventions, and future action.

Authors:  Louisa Degenhardt; Jason Grebely; Jack Stone; Matthew Hickman; Peter Vickerman; Brandon D L Marshall; Julie Bruneau; Frederick L Altice; Graeme Henderson; Afarin Rahimi-Movaghar; Sarah Larney
Journal:  Lancet       Date:  2019-10-23       Impact factor: 79.321

Review 6.  Comparison of bacterial lipopolysaccharide-induced sickness behavior in rodents and humans: Relevance for symptoms of anxiety and depression.

Authors:  Julie Lasselin; Manfred Schedlowski; Bianka Karshikoff; Harald Engler; Mats Lekander; Jan Pieter Konsman
Journal:  Neurosci Biobehav Rev       Date:  2020-05-17       Impact factor: 8.989

Review 7.  The Essential Medicinal Chemistry of Curcumin.

Authors:  Kathryn M Nelson; Jayme L Dahlin; Jonathan Bisson; James Graham; Guido F Pauli; Michael A Walters
Journal:  J Med Chem       Date:  2017-01-11       Impact factor: 7.446

8.  Expression of functional inhibitory neurotransmitter transporters GlyT1, GAT-1, and GAT-3 by astrocytes of inferior colliculus and hippocampus.

Authors:  Elsa Ghirardini; Simon L Wadle; Vanessa Augustin; Jasmin Becker; Sina Brill; Julia Hammerich; Gerald Seifert; Jonathan Stephan
Journal:  Mol Brain       Date:  2018-01-25       Impact factor: 4.041

9.  Curcumin Prevents Acute Neuroinflammation and Long-Term Memory Impairment Induced by Systemic Lipopolysaccharide in Mice.

Authors:  Vincenzo Sorrenti; Gabriella Contarini; Stefania Sut; Stefano Dall'Acqua; Francesca Confortin; Andrea Pagetta; Pietro Giusti; Morena Zusso
Journal:  Front Pharmacol       Date:  2018-03-05       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.